Enrollment complete in Phase 2 Avail™ trial of canvuparatide in hypoparathyroidism; topline results on track for Q3 2025. MBX 1416 Phase 2 trial in patients with post-bariatric ...

The EU has recently approved the use of glyphosate for another decade. Bárbara Pinho examines the controversial pesticide's ...